Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kane

Showing results (801-810 of 1,451) with videos related to

Pageof 146
Sort By:
Research Square|March 22, 2023
Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recoveryCelso Arango, Andrea Fagiolini, Philip Gorwood, et al.
Archives of Biochemistry and Biophysics|May 1, 1985
Preparation of functionally intact monomers by limited disulfide reduction of human plasma fibronectin dimersG A Homandberg, D L Amrani, D B Evans, et al.
Journal of Pain and Symptom Management|December 3, 2014
The need for palliative care in Ireland: a population-based estimate of palliative care using routine mortality data, inclusive of nonmalignant conditionsPauline M Kane, Barbara A Daveson, Karen Ryan, et al.
Proceedings of the ACM on Human-Computer Interaction|June 1, 2022
The Reintegration Journey Following A Psychiatric Hospitalization: Examining the Role of Social TechnologiesSindhu Kiranmai Ernala, Jordyn Seybolt, Dong Whi Yoo, et al.
BMC Psychiatry|June 21, 2023
Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recoveryCelso Arango, Andrea Fagiolini, Philip Gorwood, et al.
The Journal of Clinical Psychiatry|August 21, 2003
An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapineChristopher D Carlson, Patrizia A Cavazzoni, Paul H Berg, et al.
Schizophrenia Bulletin|May 20, 2021
Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia CohortDaniel Guinart, Heidi Taipale, Jose M Rubio, et al.
Circulation Research|May 1, 1992
Regulated tissue- and cell-specific expression of the human renin gene in transgenic miceC D Sigmund, C A Jones, C M Kane, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 22, 2011
Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patientsMargaret G Woerner, Christoph U Correll, Jose Ma J Alvir, et al.
The Journal of Clinical Psychiatry|September 1, 1994
Clozapine, negative symptoms, and extrapyramidal side effectsJ M Kane, A Z Safferman, S Pollack, et al.
Pageof 146

Showing results (801-810 of 1,451) with videos related to

Sort By:
Pageof 146
Research Square|March 22, 2023
Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recoveryCelso Arango, Andrea Fagiolini, Philip Gorwood, et al.
Archives of Biochemistry and Biophysics|May 1, 1985
Preparation of functionally intact monomers by limited disulfide reduction of human plasma fibronectin dimersG A Homandberg, D L Amrani, D B Evans, et al.
Journal of Pain and Symptom Management|December 3, 2014
The need for palliative care in Ireland: a population-based estimate of palliative care using routine mortality data, inclusive of nonmalignant conditionsPauline M Kane, Barbara A Daveson, Karen Ryan, et al.
Proceedings of the ACM on Human-Computer Interaction|June 1, 2022
The Reintegration Journey Following A Psychiatric Hospitalization: Examining the Role of Social TechnologiesSindhu Kiranmai Ernala, Jordyn Seybolt, Dong Whi Yoo, et al.
BMC Psychiatry|June 21, 2023
Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recoveryCelso Arango, Andrea Fagiolini, Philip Gorwood, et al.
The Journal of Clinical Psychiatry|August 21, 2003
An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapineChristopher D Carlson, Patrizia A Cavazzoni, Paul H Berg, et al.
Schizophrenia Bulletin|May 20, 2021
Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia CohortDaniel Guinart, Heidi Taipale, Jose M Rubio, et al.
Circulation Research|May 1, 1992
Regulated tissue- and cell-specific expression of the human renin gene in transgenic miceC D Sigmund, C A Jones, C M Kane, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 22, 2011
Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patientsMargaret G Woerner, Christoph U Correll, Jose Ma J Alvir, et al.
The Journal of Clinical Psychiatry|September 1, 1994
Clozapine, negative symptoms, and extrapyramidal side effectsJ M Kane, A Z Safferman, S Pollack, et al.
Pageof 146